ADVANCED HODGKIN'S LYMPHOMA: RESULTS IN 216 PATIENTS TREATED WITH ABVD IN BRAZIL

被引:0
|
作者
Britto, L. [1 ,2 ,3 ]
Biasoli, I [1 ,2 ,3 ]
Azambuja, D. [4 ,5 ]
Scheliga, A. [4 ,5 ]
Soares, A. [6 ,7 ]
Gandour, M. [1 ,2 ,3 ]
Hoffmeister, T. [1 ,2 ,3 ]
Vieites, T. [1 ,2 ,3 ]
Milito, C. [1 ,2 ,3 ]
Pulcheri, W. [1 ,2 ,3 ]
Morais, J. C. [1 ,2 ,3 ]
Spector, N. [1 ,2 ,3 ]
机构
[1] Univ Hosp, Dept Med, Rio De Janeiro, Brazil
[2] Univ Hosp, Dept Pathol, Rio De Janeiro, Brazil
[3] Univ Fed Rio de Janeiro, Sch Med, Rio De Janeiro, Brazil
[4] Inst Nacl Canc, Pathol Serv, Rio De Janeiro, Brazil
[5] Inst Nacl Canc, Oncol Serv, Rio De Janeiro, Brazil
[6] Univ Hosp, Rio De Janeiro, Brazil
[7] Univ Estado Rio De Janeiro, Sch Med, Rio De Janeiro, Brazil
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P064
引用
收藏
页码:S18 / S19
页数:2
相关论文
共 50 条
  • [21] A meta-analysis on ABVD administration in HIV plus patients with advanced stage Hodgkin's lymphoma (HL).
    Subramanian, Kritika
    Switchenko, Jeffrey M.
    Flowers, Christopher
    Khan, Mohammad Khurram
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [22] Cardiovascular and Thyroid Late Effects in Pediatric Patients With Hodgkin Lymphoma Treated With ABVD Protocol
    Ali, Nesreen
    Selim, Mustafa
    Salah, Zeinab
    El Nabarawy, Nahla M.
    Hussein, Hany
    Sidhom, Iman
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2023, 45 (04) : E455 - E463
  • [23] Clinical Presentation and Outcome of ABVD-Treated Elderly Versus Younger Patients with Classical Hodgkin's Lymphoma
    Lizeth Acosta-Maldonado, Brenda
    Ramirez-Ibarguen, Ana
    Grimaldo-Gomez, Flavio A.
    Rivas-Vera, Silvia
    BLOOD, 2014, 124 (21)
  • [24] ABVD versus BEACOPP for Hodgkin's Lymphoma REPLY
    Viviani, Simonetta
    Valagussa, Pinuccia
    Gianni, Alessandro M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (16): : 1546 - 1546
  • [25] Can we improve ABVD in Hodgkin's lymphoma?
    Gisselbrecht, Christian
    LANCET ONCOLOGY, 2013, 14 (13): : 1254 - 1256
  • [26] How the threshold of positive results influence progression free survival (PFS) in advanced Hodgkin's lymphoma treated with ABVD: experience from the International Validation Study
    Biggi, A.
    Kostakoglu, L.
    Barrington, S.
    Chauvie, S.
    Gregianin, M.
    Meignan, M.
    Hutchings, M.
    Gallamini, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S222 - S222
  • [27] Response to ABVD chemotherapeutic protocol in patients with early stage Hodgkin's lymphoma
    Diaz, Javier
    Soto, Katherine
    Ernst, Daniel
    REVISTA MEDICA DE CHILE, 2017, 145 (05) : 619 - 622
  • [28] Comparison of dose-dense ABVD and standard ABVD in the treatment of early unfavorable and advanced Hodgkin's lymphoma: A retrospective analysis
    Tao, Yun-xia
    Sun, San-yuan
    Kang, Su-yi
    Zhou, Li-qiang
    Shi, Yuan-kai
    Li, Ye-xiong
    Sun, Yan
    JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES, 2014, 34 (02) : 260 - 264
  • [29] RETROSPECTIVE STUDY OF THE IMPACT OF AGE ON THE SURVIVAL OF PATIENTS WITH HODGKIN'S LYMPHOMA OLDER THAN 50 YEARS TREATED WITH ABVD
    Lorenzo Perez, M.
    Deben Ariznavarreta, G.
    Torres Carrete, J. P.
    Varela Gomez, M. R.
    Fernandez Gabriel, E.
    Lopez Fernandez, M. F.
    Noriega Concepcion, V
    HAEMATOLOGICA, 2017, 102 : 215 - 215
  • [30] Damage to ovarian functions in young women treated with ABVD and BEACOPP chemotherapy for Hodgkin's lymphoma
    Smardova, L
    Kral, Z
    Vasova, I
    Wagnerova, B
    Vorlicek, J
    ANNALS OF ONCOLOGY, 2005, 16 : 118 - 119